Search

everythinglearnresearchcommunity

for

Search:↓

Using 5α-reductase inhibitors for hair loss can cause lasting sexual, physical, mental, and vascular health issues in men, even after stopping the medication.

Microglia, the brain's immune cells, may contribute to Polycystic Ovary Syndrome (PCOS) by altering the female brain's structure and function, with kisspeptin neurons and GABA neurotransmitters also playing a role.

Antiepileptic drugs cause cosmetic side effects like hair loss and weight gain, but patients still take their medication without it affecting their quality of life.

Testosterone's effects on COVID-19 are unclear and need more research.

Etifoxine, an anxiety drug, can lessen brain inflammation and cognitive issues in mice, partly by increasing production of protective brain steroids.

The document concludes that an experimental drug may help wound healing in Epidermolysis Bullosa, links Hydroa vacciniforme to EBV, discusses diagnosing hair loss disorders, finds many children with eczema have allergies, reviews the safety of a skin medication in children, notes side effects of a Duchenne's treatment, and identifies a marker for pediatric mastocytosis.

Yoga Nidra improves well-being and reduces anxiety in women with PCOS.

Family-based treatment is the best outpatient care for stable teens with anorexia, and more research is needed on medication and treatment effectiveness for young people with eating disorders.

Trichotillomania is more common than previously thought, with increasing diagnosed cases.

Minoxidil may protect nerves and improve hair quality during paclitaxel treatment.

New treatments for COVID-19 show promise, but more effective antiviral drugs are needed.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

DAVID syndrome is a condition with immune system and hormone deficiencies, needing early diagnosis to avoid serious complications.

Women with PCOS, especially if they are obese, are more likely to have an underactive thyroid than women without PCOS.

Patients who survive critical illness often face long-lasting physical, mental, and cognitive issues, with many unable to return to work within a year.

People with first-time vitiligo have lower levels of a certain brain protein compared to healthy individuals.

Artemisia sieversiana extract may help prevent hair loss and promote hair growth.

The document concludes that early diagnosis and a comprehensive treatment plan are crucial for managing hair loss in children, with a focus on both medical and psychological support.

New targets for making and using brain-synthesized steroids could lead to better treatments for brain disorders and alcoholism.

Lupus can look like hair loss from alopecia areata but needs different treatment.

Finasteride may cause lasting sexual and mental health issues, and genetic screening could help prevent them.

New targeted immunotherapies are improving treatment for inflammatory skin diseases.

Using mesenchymal stem cells or their exosomes is safe for COVID-19 patients and helps improve lung healing and oxygen levels.

Skin problems in COVID-19 patients are rare and may be due to the body's complex immune response or blood clotting issues.

Pramipexole can cause side effects like dizziness, sleepiness, hallucinations, and low blood pressure, and it's important to educate patients and keep doses low.

Many hospitalized children with COVID-19 had skin, mouth, or nail changes, with skin rashes being common.

In 2011, there were major scientific breakthroughs in cancer treatment, immunity, Parkinson's, virus simulation, schizophrenia, hair growth, lung cancer, and medical grafts.

Microneedle therapy combined with serum effectively increases hair count in people with hair loss, with no side effects.

Finasteride treats enlarged prostate and hair loss, but may cause side effects in some patients.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.